GYGuangyi Yang

Guangyi Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guangyi Yang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Qinhua Chen

    Shenzhen Traditional Chinese Medicine Hospital Department of Pharmacy, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine

    3 shared publications
  • Yang Yang

    Shenzhen Bao'an Authentic TCM Therapy Hospital Shenzhen Guangdong China

    3 shared publications
  • Baodong Feng

    Shenzhen Bao'an Authentic TCM Therapy Hospital Shenzhen Guangdong China

    1 shared publication
  • Chengshuo Deng

    Shenzhen Clinical College of Integrated Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Shenzhen, China

    1 shared publication
  • Helu Liu

    Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China

    1 shared publication
  • Hua Zhang

    Department of Laboratory, Sinopharm Dongfeng General Hospital, University of Medicine, Shiyan, China

    1 shared publication

Latest Publications

  • Comprehensive Chemical Profiling and Quantitative Determination of Solanum americanum Mill. and S. nigrum Linn. Combined by UHPLC‐HRMS With Feature‐Based Molecular Networking

    by Lingyi Xin, Xuemei Wei, Renyan Liu, Yun Li, Yang Yang, Yongtong Huang, Yu Zhang, Baodong Feng, Linqi Su, Quanxi Mei, et al.

    Solanum americanum Mill. and S. nigrum Linn. are traditional Solanaceae‐derived herbal medicines. Their sprouts and mature fruits are utilized as both vegetables and medicinal herbs. Although S. americanum Mill. is classified as a primary variety of S. nigrum Linn., significant pharmacological variations and incompletely characterized phytochemical profiles differentiate their applications. In this study, UHPLC/LTQ‐Orbitrap mass spectrometry (HRMS) (Thermo Fisher Scientific, USA), assisted with feature‐based molecular networking, was applied for in‐depth profiling of S. americanum Mill. and S. nigrum Linn. With the help of feature‐based molecular networking, five clusters were characterized, including flavonoids, phenylpropanoids, fatty acids, alkaloids, and steroids. S. americanum Mill. demonstrated markedly higher relative abundance in flavanols than S. nigrum Linn., potentially elucidating its distinct antioxidant activity and its anti‐inflammatory and antibacterial efficacy. In addition, metabolomics coupled with multivariate analyses screened and identified 16 discriminative chemical markers enabling differentiation between S. americanum Mill. and S. nigrum Linn. Building on the above, to elucidate the chemical basis underlying their distinct pharmacological activities, we quantified 13 identified key differential constituents of S. americanum Mill. and S. nigrum Linn. extracts by UHPLC‐QTRAP‐MS/MS using the multiple reaction monitoring (MRM) mode. The average contents of isoquercitrin, rutin, protocatechuic acid, and chlorogenic acid in S. americanum Mill. are significantly higher than those in S. nigrum Linn., suggesting that these components may serve as potential quality markers for S. americanum Mill. This study elucidates the chemical basis underlying S. americanum Mill. and S. nigrum Linn.’s pharmacological activity differences, establishes quality control tools, and supports S. americanum Mill.’s rational utilization in herbal medicine development.


  • Open Access

    Research on the application of a high-throughput fully automated bacterial growth curve monitor for screening natural antibacterial compounds

    by Shuangli Chen, Chengshuo Deng, Yixuan Liu, Xuanmei Huang, Xulong Chen, Guangyi Yang, Helu Liu

    The emergence of multidrug-resistant bacteria poses a severe challenge to infection treatment, creating an urgent need for novel antimicrobial agents. Monomers derived from natural products exhibit multi-mechanism antibacterial properties with low resistance development potential. However, evaluation of these monomers is frequently hampered by color interference in traditional turbidimetric methods. This study developed a high-throughput fully automated bacterial growth curve monitor (HTFA-BGM) to provide a new tool for screening and assessing antimicrobial monomers. The HTFA-BGM was designed and developed based on the principle of scattering nephelometry. Its performance in determining the minimum inhibitory concentration (MIC) was compared with the microdilution and the tube dilution methods. After establishing the instrument's MIC determination criterion, it was used to evaluate and screen the antibacterial effects of Traditional Chinese Medicine (TCM) monomers. The HTFA-BGM could screen MICs of 40 monomers against one strain or one monomer against 40 strains simultaneously, unaffected by compound color. When a threshold of ≤ 10% for the ratio of sample turbidity change to bacterial suspension turbidity change was used as the MIC criterion, there was no significant difference between the HTFA-BGM method and the microdilution or tube dilution methods. The HTFA-BGM was used to evaluate 15 monomers (including polyphenolic, quinonoid, and other types of compounds), and the MIC of rhein against 90 strains of Methicillin-Resistant Staphylococcus aureus (MRSA) was 8–64 μg/mL. The synergistic rates of rhein combined with penicillin, cefoxitin, cefazolin or oxacillin against MRSA in vitro were 30% (27/90), 63% (57/90), 57% (51/90), and 58% (52/90), respectively, whereas the additive rates were 70% (63/90), 37% (33/90), 43% (39/90), and 42% (38/90), respectively. The MIC of oleanolic acid against 13 isolates of vancomycin-resistant Enterococcus (VRE) was 16–32 μg/mL. When combined with vancomycin, vancomycin MIC decreased from 256–1024 to 1 μg/mL. The HTFA-BGM enables automatic, real-time, and dynamic monitoring of bacterial growth curves. Compared with the microdilution method, which determines the MIC on the basis of endpoint turbidity, this instrument not only has improved efficiency but also yields more objective and accurate results. This method specifically resolves the interference caused by the intrinsic color of colored TCM monomers such as rhein during their determination tests. Therefore, it is better suited for evaluating and screening antibacterial TCM monomers. The HTFA-BGM demonstrates excellent practical applicability and warrants broad promotion and application.


  • Gelatin-based adaptive injectable nanocomposite hydrogel for closure of irregular wounds and immunoregulation in diabetic wound healing

    by Yang Yang, Qinhua Chen, Qizhang Wang, Shuya Zhang, Jingjian Liu, Lindan Yang, Wenjing Ma, Wenqiang Li, Pingjuan Tan, Guangyi Yang


  • Open Access

    CSDR Coupling with Exo III for Ultrasensitive Electrochemistry Determination of miR-145

    by Moli Zhang, Yang Yang, Lingyi Xin, Hua Zhang, Lun Wu, Jun Zhu, Jing Zhu, Shiyun Liu, Zhaohui Wang, Qinhua Chen, et al.

    Recently, miRNAs have become a promising biomarker for disease diagnostics. miRNA-145 is closely related to strokes. The accuracy determination of miRNA-145 (miR-145) in stroke patients still remains challenging due to its heterogeneity and low abundance, as well as the complexity of the blood matrix. In this work, we developed a novel electrochemical miRNA-145 biosensor via subtly coupling the cascade strand displacement reaction (CSDR), exonuclease III (Exo III), and magnetic nanoparticles (MNPs). The developed electrochemical biosensor can quantitatively detect miRNA-145 ranging from 1 × 102 to 1 × 106 aM with a detection limit as low down as 100 aM. This biosensor also exhibits excellent specificity to distinguish similar miRNA sequences even with single-base differences. It has been successfully applied to distinguish healthy people from stroke patients. The results of this biosensor are consistent with the results of the reverse transcription quantitative polymerase chain reaction (RT-qPCR). The proposed electrochemical biosensor has great potential applications for biomedical research on and clinical diagnosis of strokes.